Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Association of Respiratory Syncytial Virus Toll-Like Receptor 3-Mediated Immune Response with COPD Exacerbation Frequency.

Liu D, Chen Q, Zhu H, Gong L, Huang Y, Li S, Yue C, Wu K, Wu Y, Zhang W, Huang G, Zhang L, Pu S, Wang D.

Inflammation. 2018 Mar;41(2):654-666. doi: 10.1007/s10753-017-0720-4.

2.

Respiratory syncytial virus hospitalization in middle-aged and older adults.

Malosh RE, Martin ET, Callear AP, Petrie JG, Lauring AS, Lamerato L, Fry AM, Ferdinands J, Flannery B, Monto AS.

J Clin Virol. 2017 Nov;96:37-43. doi: 10.1016/j.jcv.2017.09.001. Epub 2017 Sep 7.

PMID:
28942341
3.

The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review.

Colosia AD, Yang J, Hillson E, Mauskopf J, Copley-Merriman C, Shinde V, Stoddard J.

PLoS One. 2017 Aug 10;12(8):e0182321. doi: 10.1371/journal.pone.0182321. eCollection 2017. Review.

4.

Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Griffiths C, Drews SJ, Marchant DJ.

Clin Microbiol Rev. 2017 Jan;30(1):277-319. Review.

5.

RSV-specific anti-viral immunity is disrupted by chronic ethanol consumption.

Warren KJ, Simet SM, Pavlik JA, DeVasure JM, Sisson JH, Poole JA, Wyatt TA.

Alcohol. 2016 Sep;55:35-42. doi: 10.1016/j.alcohol.2016.08.001. Epub 2016 Aug 25.

6.

Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.

Mebratu YA, Smith KR, Agga GE, Tesfaigzi Y.

Respir Res. 2016 Jul 1;17(1):75. doi: 10.1186/s12931-016-0392-x.

7.

Absence of human rhinovirus and respiratory syncytial virus from bronchoalveolar lavage and bronchial biopsies of selected patients with stable chronic obstructive pulmonary disease.

Giannakaki S, Politi L, Antonogiannaki EM, Spanakis N, Arsenis G, Filaditaki V, Zakynthinos S, Karagiannidis N, Tsakris A.

Respir Res. 2016 Jan 27;17:11. doi: 10.1186/s12931-016-0323-x.

8.

Respiratory syncytial virus infection increases chlorine-induced airway hyperresponsiveness.

Song W, Yu Z, Doran SF, Ambalavanan N, Steele C, Garantziotis S, Matalon S.

Am J Physiol Lung Cell Mol Physiol. 2015 Aug 1;309(3):L205-10. doi: 10.1152/ajplung.00159.2015. Epub 2015 Jun 12.

9.

Bronchiectasis exacerbations: The role of atypical bacteria, respiratory syncytial virus and pulmonary function tests.

Metaxas EI, Balis E, Papaparaskevas J, Spanakis N, Tatsis G, Tsakris A.

Can Respir J. 2015 May-Jun;22(3):163-6. Epub 2015 Apr 15.

10.

Respiratory syncytial virus outbreak in the basic military training cAMP of the republic of Korea Air Force.

Park WJ, Yoo SJ, Lee SH, Chung JW, Jang KH, Moon JD.

J Prev Med Public Health. 2015 Jan;48(1):10-7. doi: 10.3961/jpmph.14.037. Epub 2015 Jan 14.

11.

Phosphatidylinositol inhibits respiratory syncytial virus infection.

Numata M, Kandasamy P, Nagashima Y, Fickes R, Murphy RC, Voelker DR.

J Lipid Res. 2015 Mar;56(3):578-87. doi: 10.1194/jlr.M055723. Epub 2015 Jan 5.

12.

Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.

Cagno V, Donalisio M, Civra A, Volante M, Veccelli E, Oreste P, Rusnati M, Lembo D.

Antimicrob Agents Chemother. 2014 Aug;58(8):4782-94. doi: 10.1128/AAC.02594-14. Epub 2014 Jun 9.

13.

The influence of virus infections on the course of COPD.

Frickmann H, Jungblut S, Hirche TO, GroƟ U, Kuhns M, Zautner AE.

Eur J Microbiol Immunol (Bp). 2012 Sep;2(3):176-85. doi: 10.1556/EuJMI.2.2012.3.2. Epub 2012 Sep 10. Review.

14.

Virus-induced exacerbations in asthma and COPD.

Kurai D, Saraya T, Ishii H, Takizawa H.

Front Microbiol. 2013 Oct 1;4:293. doi: 10.3389/fmicb.2013.00293. Review.

15.

Lung microbiology and exacerbations in COPD.

Beasley V, Joshi PV, Singanayagam A, Molyneaux PL, Johnston SL, Mallia P.

Int J Chron Obstruct Pulmon Dis. 2012;7:555-69. doi: 10.2147/COPD.S28286. Epub 2012 Aug 31. Review.

16.

Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.

Donalisio M, Rusnati M, Cagno V, Civra A, Bugatti A, Giuliani A, Pirri G, Volante M, Papotti M, Landolfo S, Lembo D.

Antimicrob Agents Chemother. 2012 Oct;56(10):5278-88. doi: 10.1128/AAC.00771-12. Epub 2012 Jul 30.

17.

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults.

Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK.

J Infect Dis. 2012 Jul 1;206(1):56-62. doi: 10.1093/infdis/jis309. Epub 2012 Apr 23.

18.

Progress in respiratory virus vaccine development.

Schmidt AC.

Semin Respir Crit Care Med. 2011 Aug;32(4):527-40. doi: 10.1055/s-0031-1283289. Epub 2011 Aug 19. Review.

19.

Respiratory syncytial virus infection in human bone marrow stromal cells.

Rezaee F, Gibson LF, Piktel D, Othumpangat S, Piedimonte G.

Am J Respir Cell Mol Biol. 2011 Aug;45(2):277-86. doi: 10.1165/rcmb.2010-0121OC. Epub 2010 Oct 22.

20.

Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease.

Bannister R, Rodrigues D, Murray EJ, Laxton C, Westby M, Bright H.

Virol J. 2010 Sep 22;7:250. doi: 10.1186/1743-422X-7-250.

Supplemental Content

Support Center